Username: Password:
Introductions to authors



Reproductive Biotechnology is the official journal of the Society of Asian Reproductive Biotechnology (ARBS). It was established in 2004 to promote the educational and scientific interests of the reproductive biotechnology research community throughout Asia. The society includes active scientists and students working in many Asian countries, including Japan, South Korea, China, Vietnam, Thailand, Indonesia, Malaysia, India, Singapore, Bangladesh, Taiwan, Lao and Cambodia etc..and serves as the region's premiere forum for scientific discussion and exchange in this field.

Reproductive Biotechnology publishes original research articles and topical reviews on the subject of reproductive biotechnology. Its focus is on cellular and molecular biology of reproduction, including the development of gametes and early embryos in all animal species including the human; developmental processes such as cell differentiation, morphogenesis and related regulatory mechanisms in normal and disease models; assisted reproductive technologies in model systems and in a clinical environment; reproductive endocrinology; reproductive immunology; genomic reprogramming, and epigenetic reprogramming. Emerging topics including the biology of embryonic stem cells, adult stem cells, spermatogonia stem cells, and ovary stem are encouraged.

Editorial policy

Reproductive Biotechnology
publishes research papers that extend our understanding of mechanisms of reproductive biology, novel reproductive biotechnology and stem cells research. Papers of a descriptive or technical nature will only be published when they open new lines of research and are of interest to the wide readership of the journal. When submitting your manuscript please explain clearly and succinctly in the covering letter how your research advances present knowledge of reproductive biology and Biotechnology. This will be important for the expert editor handling your paper to determine its suitability for the journal. Papers that are not within the remit of the journal may be rejected by the relevant experts on the editorial board. Decisions to reject papers at this stage will be taken by two editors, normally within a week of the manuscript being submitted. A brief explanation as to why the manuscript does not meet the journal's requirements for publication will be returned to the author.

Ethical guidelines for Reproductive Biotechnology

Reproductive Biotechnology is committed to integrity in scientific research. In order to ensure that the journal's contribution to the scientific record is reliable and meets the ethical standards expected by the global scientific community, we have developed the following code of ethics to support editors, authors and peer reviewers in understanding the standards of behavior they should follow in carrying out their roles in the journal publishing process.


Articles are considered on the understanding that, if they are accepted for publication, the entire copyright shall pass to the Society of Reproductive Biotechnology. All authors are asked to sign a copyright agreement to this effect. To facilitate the processing of your manuscript please submit the completed form with your paper.

Publication costs

At the time of submission, authors must agree to honor publication charges if the manuscript is accepted. The current publication costs are as follows:

Research paper: Developed Countries Developing Countries*
500 USD
300 USD

Review paper: Developed Countries Developing Countries*
500 USD
300 USD

*List of developing countries as defined by the World Bank in September 2010 (See the current World Bank listing here).

Research papers

Research papers should be substantial bodies of work describing original research that provides insight into: the cellular and molecular biology of reproduction, Assisted Reproductive technologies (ART) and Biotechnology, genomic reprogramming, epigenetic reprogramming, the biology of embryonic stem cells, adult stem cells, spermatogonia stem cells, and ovary stem cells etc..
Manuscripts should be concise and clear. As a guideline, the total length of the manuscript should not exceed 50,000 characters (excluding spaces and References). We recommend a maximum of 10 figures and 50 references.
Manuscripts should be divided into the following sections: Title page, Abstract, Introduction, Results, Discussion, Materials and Methods, Acknowledgements, References, Figure legends, Tables, Figures.

Reviews Paper

Reviewrs papers must be highly focused and address a specific new concept, area of controversy, or deficiency of data in a specific area. They are not intended to highlight recent accomplishments of personnel associated with a single laboratory. Minireviews must provide new insights and directions for future research.

For review papers, authors will be assessed page charges at the current rate shown in publication costs and should follow the Instructions for Authors.


The manuscripts must be submitted online at The Editorial Office is committed to processing manuscripts as rapidly as possible without compromising the quality or integrity of the journal. To expedite the review and, eventually, the production phases of publication, manuscripts must be prepared according to the Instructions for Authors. On average, authors receive reviewers?? comments within 1 month of submission.

Authors can be submitted MS to the Editorial Office via e-mail:

Review process

Every manuscript meeting submission criteria will be assigned to an Associate Editor (AE) whose expertise covers the research area of the manuscript. The AE will select reviewers. The selected reviewers will be contacted by e-mail and may view the abstract before accepting a review assignment. Reviewers are asked to return reviews within 15 days; reminders are sent to reviewers at appropriate intervals. The reviewers will rate the importance, originality, and overall suitability of the manuscript according to the criteria detailed above. Reviewers will also comment on the appropriateness of the statistical methods and the use of animal and/or human subjects/tissue, if applicable to the manuscript. The AEs will evaluate the reviews and recommend a decision to the Editors-in-Chief. The Editors-in-Chief will render the decision. Manuscripts submitted by the Editors-in-Chief will be handled by a consulting editor selected by the Board of Directors. Manuscripts submitted by AEs will be handled by the Editors-in-Chief.


Decisions are "Accept", "Conditional Acceptance", "Accepted Only If Appropriately Revised", and "Reject".

Manuscripts that receive the decision "Accepted if Appropriately Revised" or "Conditional Acceptance" may be revised and submitted only once for rereview. If Authors decide not to submit a revision, they must formally withdraw the manuscript, using options in the online submission process. Revised manuscripts must be received by the Editorial Office within 90 days of the date of first decision; if a revised manuscript is received after the 90-day period, it will be treated as a new manuscript or a resubmission. If authors find that an extension is necessary, they must formally request an extension from the Editors-in-Chief in writing.


Papers may be withdrawn at any stage prior to acceptance. A written request, including the reason(s) for withdrawal, must be sent to the Editors-in-Chief. The Editors-in-Chief will respond to the authors and notify editorial staff to formally withdraw the submission behalf of the authors. Authors will receive an e-mail notification that the paper is no longer under consideration by Reproductive Biotechnology. If the paper is resubmitted at a later date, authors must provide the previous manuscript ID number in their cover letter.


Final publication of accepted papers occurs within two months of acceptance; the accepted, peer-reviewed version is published online in Reprodbiotech-Papers In Press as soon after acceptance as possible. Accepted manuscripts are subjected to light copyediting to correct grammar and impose standard journal style. All papers accepted for publication will appear first in Reprodbiotech-Papers in Press in the reviewed but unedited version and then, after copyediting in the full-text, searchable online version (, the journal of record.


If a paper must be retracted after it has been published, a complete explanation must be submitted to the Editors-in-Chief in writing and be signed by all authors. Upon examination, if it is found that the paper must be retracted, the following procedure will be followed:
Upon notification from the Editors-in-Chief, editorial staff will provide authors with a form that must be completed, signed by all authors, and returned to the Editorial Office.
Upon receipt of this document, editorial staff will post the retraction with the next available Papers In Press posting.


File Formats

For manuscript text and tables, our preferred file format is Microsoft Word (.doc), but other word-processing formats can be submitted. For MS Office 2007, please save documents as Word 97-2003 format. Please provide tables in a separate file to the text. We recommended that at initial submission, you mDF file containing all text and figures.

Title page

Include a separate title page with the title, authors names and full addresses; use superscript numbers after authors names for addresses.
Title: Use upper and lower case letters. Please make the title a clear and concise summary of your specific findings and avoid specialist abbreviations.
- Provide a short title of not more than 40 characters (including spaces) as a running head.
- Indicate the person to whom correspondence should be addressed (include email address).

Summary sentence: One-sentence summary of the manuscript's significance (limited to 250 characters.


The abstract should be a single paragraph of not more than 250 words. State clearly the objective of the study or review, the methods used (where applicable), and summarize results and conclusions.
Do not cite references. Avoid abbreviations and acronyms.


Provide a clear statement of the problem and cite the relevant literature on the subject; follow this with a concise statement of the objectives of the study.

Materials and methods

Sufficient information should be provided so that other workers can repeat the study. If well-established methods are used give a reference to the technique; full details of any modifications should be provided. Use generic names of chemicals, drugs, antibodies, reagents, enzymes, etc.; avoid using brand names unless the composition of a particular brand is critical to the methodology. Please provide institutional affiliations of individuals or companies who have donated supplies or reagents. Include statistical methods used for data analysis. Do not describe methods in figure legends.
The full binomial Latin names should be given for all experimental animals other than common laboratory animals. State also the breed or strain and source of animals, and give details of age, weight, sex and housing.


Present findings in appropriate detail and refer to tables and figures in order, but without discussion.
  • Nucleotide sequences should be submitted to GenBank (, EMBL (, or DNA Data Bank of Japan ( database, and the accession number and date of accession should be noted in the text. Providing the link saves space and takes the reader directly to the complete information. If you do need to include sequence information, they must be presented as figures, not tables, or, preferably, included as Supplemental Data.
  • Genomic and proteomic data should be deposited with the NCBI gene expression and hybridization array data repository (GEO,

Provide a clear and concise interpretation of the results; avoid redundant summaries.


Acknowledge assistance other than financial support, e.g., technical help, editorial assistance, etc.

We recommend a maximum of 50 references. Authors bear total responsibility for the accuracy of all references. All references cited in the text should be included in the reference list.
  • Include only references that appear in peer-reviewed publications or other published works that are accessible to most scientists.
  • Only published articles or articles accepted for publication qualify as references. Articles that have been "conditionally accepted", and "submitted" are not acceptable.
  • Abstracts in proceeding of conferences may not be used as references.
  • Cite personal communications and unpublished data only if necessary; please provide the name or names of individuals associated with the unpublished data, e.g., (Van Thuan and Wakayama or Van Thuan et al., unpublished data).
Use the following style:

Wakayama S, Kishigami S, Van Thuan N, Ohta H, Hikichi T, Mizutani E, Yanagimachi R, Wakayama T. Propagation of an infertile hermaphrodite mouse lacking germ cells by using nuclear transfer and embryonic stem cell technology. Proc Natl Acad Sci U S A. 2005; 102:29-33.

Bui HT, Wakayama S, Kishigami S, Park KK, Kim JH, Van Thuan N, Wakayama T. Effect of trichostatin A on chromatin remodeling, histone modifications, DNA replication, and transcriptional activity in cloned mouse embryos. Biol Reprod. 2010 (in press).

In the text
Cite references in the text in chronological order and use et al. for more than two authors, eg: (Van Thuan & Wakayama 2010; Wakayama et al. 2010; Wakayama 2010).


Tables should be concise and informative. The title should be a single sentence at the head of the table. Give a short heading for each column, and do not use internal horizontal and vertical lines.
Any additional explanatory material should appear as footnotes, cross-referenced to the column entries. Explain all abbreviations used in the table in the footnotes.


Reproductive Biotechnology is committed to publishing high quality figures.
EPS or TIFF files are preferred; files should be exported in Illustrator compatible format. Any Photoshop (TIFF or JPEG) or PDF files should be at least 300 dpi at the final published width (avoid using PowerPoint files).
Label figure sections as A, B etc in the top left-hand corner. Indicate magnification by a scale bar in the bottom right-hand corner of the image; give the measurement in the legend. Arial font is preferred for text labels.
Include legends to all figures, giving the figure number, keys to any symbols used and the name of the organism studied.
Please contact the Editorial Office for more information: e-mail:

Supplementary data

Supplemental data may be submitted online at the time of submission. It is the authors' responsiblity to indicate in the cover letter if the data are for review purpose only or if the data are intended for publication with the online versions. If for review-purposes only, include text with the supplemental file indicating "for review purposes only".
File size limit for supplementary data: 5 MB for figures and tables, 10 MB for movies. Acceptable format for Figures: TIFF, JPEG, PDF. Acceptable format for Tables: PDF. Acceptable format for movies: MOV, MPEG.
The total number of Supplemental Data Files is not exceed 10 files and the total number of megabutes is not exceed 10 MB.